Speciality: Pulmonary Medicine
Description:
A warm welcome to all the medical professionals in this interesting session on the role of omalizumab in severe allergic asthma.
Omalizumab is a monoclonal antibody used to treat severe allergic asthma. It targets and binds to immunoglobulin E (IgE), a key player in allergic reactions. By reducing the amount of free IgE, omalizumab helps prevent allergic triggers from activating immune cells that lead to asthma symptoms.
For people with severe asthma, omalizumab can significantly reduce the frequency of asthma attacks. It works by decreasing airway inflammation, helping improve lung function and control symptoms that don't respond well to traditional inhalers or medications.
This treatment is typically given by injection and prescribed for individuals whose asthma is driven by allergies. Many patients experience fewer symptoms and a lower need for corticosteroids, which can help reduce long-term side effects associated with other treatments.
Therefore, get an overall knowledge of the role of omalizumab in severe allergic asthma. Listen to the webinar, grab the shared knowledge, and follow Hidoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Chemo-Free Regimen for Ph+ ALL Yields High Rate of Deep MRD Negativity
2.
Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.
3.
Cancer diagnosis does not spur improvements to survivors' diets or eating habits
4.
Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.
5.
Microplastics can cause malignant changes in lung cells
1.
Exploring the Potential of Cytologic Atypia in Cancer Diagnosis
2.
Personalized Cancer Vaccines: The Next Frontier in Precision Oncology
3.
AI-Powered Rehabilitation: A Game Changer for Hemophilia Management
4.
Targeting the Tumor Microenvironment: Next-Generation Strategies for Immuno-Oncology Success
5.
Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Current Scenario of Cancer- The Incidence of Cancer in Men
4.
Navigating the Complexities of Ph Negative ALL - Part I
5.
From Relapse to Remission : Chasing the Invisible and Redefining Long-Term Survival in Adult R/R B-Cell ALL
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation